Literature DB >> 7021284

The effect of treatment of type 2 (insulin independent) diabetes mellitus on plasma concentrations of pancreatic polypeptide and glucagon.

D Berger, J C Floyd, S B Pek.   

Abstract

The effect of the control of diabetes with diet and insulin upon plasma levels of human pancreatic polypeptide and glucagon was determined in eight patients with Type 2 (insulin independent) diabetes mellitus. The mean +/- SEM fasting plasma glucose was 15.9 +/- 1.3 mmol/l for 5 days of diet treatment and 5.9 +/- 0.4 mmol/l for the last 5 days of treatment with diet plus insulin (p less than 0.0001); corresponding fasting plasma pancreatic polypeptide levels were 328 +/- 97 and 247 +/- 71 pg/ml (p less than 0.05) and immunoreactive glucagon levels were 95 +/- 11 and 62 +/- 6 pg/ml (p less than 0.005). Cooked ground beef was administered on the first day of diet treatment and on the last day of treatment with diet plus insulin; mean maximal rise of pancreatic polypeptide, and total and incremental plasma pancreatic polypeptide response areas were significantly lower following treatment (p less than 0.01), as was total area for immunoreactive glucagon (p less than 0.05). Normalisation of fasting plasma glucose by short-term treatment with diet plus insulin is associated with decreases in basal and stimulated secretory activity of the pancreatic polypeptide cells in insulin independent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021284     DOI: 10.1007/bf00251278

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  A newly recognized pancreatic polypeptide; plasma levels in health and disease.

Authors:  J C Floyd; S S Fajans; S Pek; R E Chance
Journal:  Recent Prog Horm Res       Date:  1976

2.  Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum.

Authors:  R J Bondar; D C Mead
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

3.  Computer program sequence for analysis and summary of radioimmunoassay data.

Authors:  W G Duddleson; A R Midgley; G D Niswender
Journal:  Comput Biomed Res       Date:  1972-06

Review 4.  Glucagon and the A cells.

Authors:  R H Unger; P Raskin; C B Srikant; L Orci
Journal:  Recent Prog Horm Res       Date:  1976

5.  Regulation in healthy subjects of the secretion of human pancreatic polypeptide, a newly recognized pancreatic islet polypeptide.

Authors:  J C Floyd; S S Fajans; S Pek
Journal:  Trans Assoc Am Physicians       Date:  1976

6.  Reduced pancreatic polypeptide secretion in obese subjects.

Authors:  J Marco; M A Zulueta; I Correas; M L Villanueva
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

7.  Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.

Authors:  M Hayashi; J C Floyd; S Pek; S S Fajans
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

8.  Effect of age on fasting plasma levels of pancreatic hormones in man.

Authors:  D Berger; R C Crowther; J C Floyd; S Pek; S S Fajans
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

9.  Synchronous oscillations in the basal secretion of pancreatic-polypeptide and gastric acid. Depression by cholinergic blockade of pancreatic-polypeptide concentrations in plasma.

Authors:  T W Schwartz; B Stenquist; L Olbe; F Stadil
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Is pancreatic polypeptide a marker for Zollinger-Ellison syndrome?

Authors:  I L Taylor; J H Walsh; J Rotter; E Passaro
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  5 in total

1.  Gallbladder emptying and cholecystokinin and pancreatic polypeptide responses to a liquid meal in patients with diabetes mellitus.

Authors:  T Meguro; T Shimosegawa; A Satoh; H Suzuki; A Takasu; A Takayama; M Koizumi; T Toyota
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

2.  Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the rat.

Authors:  M M O'Hare; C Shaw; S K Swanston-Flatt; M Marcelli; K D Buchanan; P R Flatt
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

3.  Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.

Authors:  Elisabeth M H Mathus-Vliegen; Gerrit H de Groot
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

4.  Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.

Authors:  G Dimitriadis; P Cryer; J Gerich
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

5.  Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion.

Authors:  Yanyun Zhao; Yue Zhou; Min Xiao; Yajing Huang; Mengmeng Qi; Zili Kong; Jingwei Chi; Kui Che; Wenshan Lv; Bingzi Dong; Yangang Wang
Journal:  J Diabetes       Date:  2022-04-19       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.